Biomx Ltd (PHGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,862 | -13,696 | -7,659 | -17,727 | -3,214 |
| Depreciation Amortization | 1,769 | 528 | 236 | 2,604 | 1,683 |
| Accounts payable and accrued liabilities | -3,207 | -2,110 | -1,288 | -4,151 | -3,860 |
| Other Working Capital | -1,410 | -1,011 | -1,040 | -4,969 | -6,230 |
| Other Operating Activity | 3,706 | 1,468 | 1,039 | -12,736 | -19,069 |
| Operating Cash Flow | $-22,004 | $-14,821 | $-8,712 | $-36,979 | $-30,690 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 107 | 109 | 51 | 52 | 53 |
| Net Acquisitions | N/A | N/A | N/A | 663 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 663 |
| Investing Cash Flow | $107 | $109 | $51 | $715 | $716 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -10,747 | -10,747 |
| Common Stock Issued | 12,056 | 12,002 | 12,000 | 28,770 | 28,770 |
| Other Financing Activity | -118 | -118 | -87 | 20,351 | 20,749 |
| Financing Cash Flow | $11,938 | $11,884 | $11,913 | $38,374 | $38,772 |
| Exchange Rate Effect | 53 | 39 | 3 | 1 | -11 |
| Beginning Cash Position | 17,975 | 17,975 | 17,975 | 15,864 | 15,864 |
| End Cash Position | 8,069 | 15,186 | 21,230 | 17,975 | 24,651 |
| Net Cash Flow | $-9,906 | $-2,789 | $3,255 | $2,110 | $8,787 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,004 | -14,821 | -8,712 | -36,979 | -30,690 |
| Capital Expenditure | -2 | N/A | N/A | -30 | -19 |
| Free Cash Flow | -22,006 | -14,821 | -8,712 | -37,009 | -30,709 |